About
13.67AUD+0.63 +4.83%
Closed • Updated at 17:00 GMT+00:00Market Cap$1.18B
P/E Ratio58.72
Volume381.8K
Beta1.80
RSI62.55
Gross Margin99.96%
Neuren Pharmaceuticals Limited — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Q1 2026 DAYBUE net sales US$101m, up 20% from Q1 2025
Apr 8 2026
DAYBUE STIX now broadly available in US for Rett syndrome
Mar 3 2026
Acadia confirms plan to request CHMP re-examination
Feb 27 2026
2025 royalty income A$65m, profit after tax A$30m
Feb 27 2026
Appendix 4E and 2025 full year accounts
Translate